Anticancer Therapy at the End of Life: Lessons From a Community Cancer Institute
Shanthi Sivendran(Lancaster General Hospital), Kristina Newport(Pennsylvania State University), Jason H. Moore(Cedars-Sinai Medical Center), Riley Wong(University of Pennsylvania), Selah Lynch(University of Pennsylvania), Caitlyn McNaughton(Lancaster General Hospital), Sarah Svetec(American Institutes for Research), Randall A. Oyer(Lancaster General Hospital), Rachel Holliday(Lancaster General Hospital)
Cited by 5
Related Papers
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521
Breast cancer risk–associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression
|Nature Genetics|2012|379
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
|Journal of Clinical Oncology|2022|238
GAMETES: a fast, direct algorithm for generating pure, strict, epistatic models with random architectures
|BioData Mining|2012|229
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
|Journal of the American Heart Association|2017|136